SMITH, Renee M., Sudarshan RAI, Peter KRUŽLIAK, Alan HAYES a Anthony ZULLI. Putative Nox2 inhibitors worsen homocysteine-induced impaired acetylcholine-mediated relaxation. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. OXFORD: ELSEVIER SCI LTD, 2019, roč. 29, č. 8, s. 856-864. ISSN 0939-4753. Dostupné z: https://dx.doi.org/10.1016/j.numecd.2019.05.051.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Putative Nox2 inhibitors worsen homocysteine-induced impaired acetylcholine-mediated relaxation
Autoři SMITH, Renee M. (36 Austrálie, garant), Sudarshan RAI (36 Austrálie), Peter KRUŽLIAK (703 Slovensko, domácí), Alan HAYES (36 Austrálie) a Anthony ZULLI (36 Austrálie).
Vydání NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, OXFORD, ELSEVIER SCI LTD, 2019, 0939-4753.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30201 Cardiac and Cardiovascular systems
Stát vydavatele Velká Británie a Severní Irsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.700
Kód RIV RIV/00216224:14110/19:00111782
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.numecd.2019.05.051
UT WoS 000476511900012
Klíčová slova anglicky Acetylcholine; Acetylcholine-mediated vasorelaxation; Homocysteine; Nox2; Pharmacology
Štítky 14110121, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 24. 1. 2020 14:47.
Anotace
Background and aim: Increased homocysteine (Hcy) is associated with coronary artery disease (CAD). Hcy increases reactive oxygen species (ROS) via NADPH oxidases (Nox), reducing acetylcholine-mediated vasorelaxation. We aimed to determine if putative Nox2 inhibitors prevent Hcy-impaired acetylcholine-mediated vasorelaxation. Methods and results: New Zealand White rabbit and wild-type (C57BL/6) and Nox2(-/-) (NOX) mice aortic rings were mounted in organ baths. Rabbit rings were incubated with either apocynin (10 mu M), gp91ds-tat (GP, 1 mu M) or PhoxI2 (1 mu M) and mice rings GP (1 mu M) only. Some rabbit rings were incubated with 3 mM Hcy, before pre-contraction, followed by dose-response relaxation to acetylcholine (ACh; 0.01 mu M-10 mu M). In rabbit rings treated with Hcy and GP, O-2(-) donor pyrogallol (1 mu M) or Akt activator SC79 (1 mu M) was added 5 min before ACh. Mice rings were used to compare Nox2 deletion to normal acetylcholine-mediated relaxation. In rabbits, Hcy reduced acetylcholine-mediated relaxation vs. control (p < 0.0001). Treatment + Hcy reduced relaxation compared with treatment alone (p < 0.0001). Pyrogallol and SC79 reversed the response of GP + Hcy (p = 0.0001). In mice, Nox2 deletion reduced acetylcholine-mediated vasorelaxation. Rabbit tissue analysis revealed that Hcy reduced eNOS phosphorylation at Thr(495) and increased eNOS phosphorylation at Ser(1177); no further alteration at Thr(495) was observed with GP. In contrast, GP prevented increased phosphorylation at Ser(1177). Conclusions: Apocynin, GP and PhoxI2 worsens acetylcholine-mediated vascular relaxation in rabbit aorta, which is supported by results from mouse Nox2 deletion data. These inhibitors worsen Hcy-induced vascular dysfunction, suggesting that current putative Nox2 inhibitors might not be useful in treating HHcy. (C) 2019 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
VytisknoutZobrazeno: 11. 9. 2024 04:07